Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Common Equity (2016 - 2025)

Historic Common Equity for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $442.5 million.

  • Orthofix Medical's Common Equity fell 1586.5% to $442.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $442.5 million, marking a year-over-year decrease of 1586.5%. This contributed to the annual value of $503.1 million for FY2024, which is 1596.81% down from last year.
  • Orthofix Medical's Common Equity amounted to $442.5 million in Q3 2025, which was down 1586.5% from $458.3 million recorded in Q2 2025.
  • Over the past 5 years, Orthofix Medical's Common Equity peaked at $664.2 million during Q1 2023, and registered a low of $333.5 million during Q3 2022.
  • Over the past 5 years, Orthofix Medical's median Common Equity value was $458.3 million (recorded in 2025), while the average stood at $462.6 million.
  • Its Common Equity has fluctuated over the past 5 years, first surged by 9791.67% in 2023, then tumbled by 1964.2% in 2025.
  • Over the past 5 years, Orthofix Medical's Common Equity (Quarter) stood at $336.9 million in 2021, then decreased by 0.02% to $336.9 million in 2022, then surged by 77.74% to $598.7 million in 2023, then decreased by 15.97% to $503.1 million in 2024, then decreased by 12.05% to $442.5 million in 2025.
  • Its Common Equity stands at $442.5 million for Q3 2025, versus $458.3 million for Q2 2025 and $458.3 million for Q1 2025.